Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03933878 · ClinicalTrials.gov registry record
Rapid Detection of Airway Pathogens for Lung Transplantation
A clinical trial of Respiratory Tract Infections and Lung Transplantation, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03933878 is a study of Respiratory Tract Infections and Lung Transplantation that has completed, run by University of California, San Francisco. The registered enrollment target is 200 participants, below the 2,761-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03933878, a study of Respiratory Tract Infections and Lung Transplantation, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Pneumonias and lower respiratory tract infections can have important long-term consequences, particularly in the context of lung transplantation, where pneumonia is a major cause of death. Candidate organs and lung transplant recipients undergo bronchoscopic inspection to assess for lower respiratory tract infection, but traditional culture methods take time, leading to increased risk from inappropriate therapy. The investigators hypothesize that the rapid detection of lower respiratory tract infection, using a semi-quantitative multiplex molecular assay, can decrease the time to appropriate clinical decision making.
Conditions Studied
Study Locations (1)
California
- UCSF Parnassus - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-03-19 |
| Est. Completion | 2021-03-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03933878
The ClinicalTrials.gov registry entry for NCT03933878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,761-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (93% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Respiratory Tract Infections appearing as the primary indexed condition, and to 0 interventions.
NCT03933878 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03933878 about?
NCT03933878 is a clinical study titled "Rapid Detection of Airway Pathogens for Lung Transplantation". Pneumonias and lower respiratory tract infections can have important long-term consequences, particularly in the context of lung transplantation, where pneumonia is a major cause of death. Candidate organs and lung transplant recipients undergo bronchoscopic inspection to assess for lower respirator...
What is the current status of trial NCT03933878?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2019-03-19. Estimated completion is 2021-03-05.
What conditions does trial NCT03933878 study?
This clinical trial studies the following conditions: Respiratory Tract Infections, Lung Transplantation, Pulmonary Infection.
Who is sponsoring clinical trial NCT03933878?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03933878 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
RECRUITING · NA
-
Beetroot Juice NO Cold Study
RECRUITING · Phase 2
-
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.